Pro-Dex, Inc.

NasdaqCM PDEX

Pro-Dex, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending September 30, 2024: 9.17%

Pro-Dex, Inc. Net Income Margin is 9.17% for the Trailing 12 Months (TTM) ending September 30, 2024, a -24.32% change year over year. Net Income Ratio, also known as the profit margin, is the ratio of net income to net sales, showing the percentage of revenue that remains as profit after all expenses are deducted.

Pro-Dex, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending September 30, 2023 was 12.12%, a 35.13% change year over year.
Pro-Dex, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending September 30, 2022 was 8.97%, a -16.78% change year over year.
Pro-Dex, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending September 30, 2021 was 10.77%, a -37.85% change year over year.
Pro-Dex, Inc. Net Income Margin for the Trailing 12 Months (TTM) ending September 30, 2020 was 17.34%, a 22.13% change year over year.

Key data

Date	Net Income Margin	EBITDA Margin	EBIT Margin	EBITDA

NasdaqCM: PDEX

Pro-Dex, Inc.

CEO	Mr. Richard Lee Van Kirk Jr.
IPO Date	Aug. 7, 1986
Location	United States
Headquarters	2361 McGaw Avenue
Employees	146
Sector	Health Care
Industries Medical Instruments

Description

Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.

Key trends

Past 5 years